Rise of Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Rise of Clinical Trials in Mexico

Rise of Clinical Trials in Mexico – Clinical Trials in Latin America

In recent years, Mexico has emerged as a significant player in the global clinical trials landscape. With a growing healthcare infrastructure, a large and diverse population, and favorable regulatory changes, Mexico has become an attractive destination for pharmaceutical companies and researchers looking to conduct clinical trials.

This article explores the rise of clinical trials in Mexico, the factors contributing to this growth, and the potential impact on the country’s healthcare sector and economy.

The Evolution of Clinical Trials in Mexico

Clinical trials have a long history in Mexico, dating back to the early 20th century when researchers conducted studies on diseases like yellow fever and tuberculosis. However, it is in the last two decades that clinical trials in Mexico have seen substantial growth. This expansion can be attributed to several key factors:

  1. Regulatory Reforms: Mexico’s regulatory environment underwent significant reforms, aligning its clinical trial regulations with international standards. The Federal Commission for the Protection against Sanitary Risk (COFEPRIS) introduced streamlined processes for trial approval, reducing bureaucratic hurdles and timelines.
  2. Access to Diverse Patient Populations: Mexico boasts a diverse population, making it an ideal location for clinical trials that require a broad range of patient demographics. This diversity helps in assessing a drug’s safety and efficacy across various genetic backgrounds.
  3. Cost-Effective Trials: Conducting clinical trials in Mexico can be more cost-effective than in developed countries. Lower labor costs, affordable healthcare services, and reduced administrative burdens make it an attractive destination for pharmaceutical companies.
  4. Increasing Healthcare Infrastructure: Mexico has steadily improved its healthcare infrastructure, with world-class hospitals and research centers in major cities like Mexico City, Monterrey, and Guadalajara. This infrastructure supports clinical trial facilities and services.
  5. Collaborative Research Ecosystem: Collaboration between pharmaceutical companies, academic institutions, and government agencies has led to the development of a robust research ecosystem in Mexico. These partnerships facilitate the design and execution of high-quality clinical trials.

Rise of Clinical Trials in Mexico

Rise of Clinical Trials in Mexico

Rise of Clinical Trials in Mexico

The Economic Impact

The rise of clinical trials in Mexico has not only benefited the healthcare sector but also the country’s economy as a whole. Here’s how:

  1. Job Creation: Clinical trials require a skilled workforce, including clinical research coordinators, nurses, and data analysts. As the number of trials increases, so do employment opportunities in the healthcare and research sectors.
  2. Investment Inflow: Pharmaceutical companies and sponsors invest significantly in clinical trials, pumping money into Mexico’s economy. This funding can be used for infrastructure development and capacity-building.
  3. Intellectual Property and Innovation: Clinical trials often involve cutting-edge treatments and technologies. As Mexico becomes a hub for these trials, it can foster innovation in the healthcare sector, potentially leading to the development of new therapies and medical devices.
  4. Enhanced Healthcare Infrastructure: The infrastructure improvements made to accommodate clinical trials also benefit the general population by providing access to better healthcare facilities and services.

Challenges and Ethical Considerations

While the rise of clinical trials in Mexico presents numerous opportunities, it also raises important challenges and ethical considerations:

  1. Informed Consent: Ensuring that participants fully understand the risks and benefits of clinical trials is crucial. Language barriers and varying levels of health literacy can complicate the informed consent process.
  2. Regulatory Oversight: While regulatory reforms have improved the clinical trial landscape, ongoing vigilance is necessary to prevent any potential ethical violations or exploitation of vulnerable populations.
  3. Access to Trial Results: Transparency in reporting trial results is vital to maintain trust in the clinical trial process. Ensuring that data is made available to the scientific community and the public is essential.
  4. Healthcare Disparities: The benefits of clinical trials should be accessible to all socioeconomic groups in Mexico. Efforts must be made to address healthcare disparities and ensure equitable access to trials.


The rise of clinical trials in Mexico is a testament to the country’s growing prominence in the global healthcare and pharmaceutical research arena. With a favorable regulatory environment, diverse patient populations, and a collaborative research ecosystem, Mexico has become an attractive destination for clinical trials.

This trend not only boosts the country’s economy but also holds the potential to drive innovation and improve healthcare outcomes for its citizens. However, ethical considerations and challenges must be addressed to ensure that clinical trials in Mexico are conducted responsibly and ethically, benefiting both the scientific community and the general population.

As Mexico continues to evolve as a hub for clinical research, it is poised to play an increasingly significant role in shaping the future of medicine and healthcare worldwide.

Rise of Clinical Trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Rise of Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Rise of Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Rise of Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Rise of Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Rise of Clinical Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Rise of Clinical Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Rise of Clinical Trials in Mexico

The Cohortias Team

Rise of Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Rise of Clinical Trials in Mexico

Network & Partnerships